Class II Alloantibody and Mortality in Simultaneous Liver-Kidney Transplantation

Bortezomib for Acute Antibody-Mediated Rejection in Liver Transplantation

(2012) F. Paterno et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation

(2012) Hugo Kaneku et al.   LIVER TRANSPLANTATION

Antibody-Mediated Rejection-An Ounce of Prevention Is Worth a Pound of Cure

(2011) J. A. Bradley et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Donor-Directed MHC Class I Antibody Is Preferentially Cleared from Sensitized Recipients of Combined Liver/Kidney Transplants

(2011) W. Dar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Novel Pathway of Chronic Allograft Rejection Mediated by NK Cells and Alloantibody

(2011) T. Hirohashi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

High Mean Fluorescence Intensity Donor-Specific Anti-HLA Antibodies Associated With Chronic Rejection Postliver Transplant

(2011) J. G. O’Leary et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation

(2011) A. I. Musat et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Combined Liver-Kidney Transplants: Allosensitization and Recipient Outcomes

(2011) Medhat Askar et al.   TRANSPLANTATION

Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility

(2008) Marcela Castillo-Rama et al.   LIVER TRANSPLANTATION